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IMAGES IN GENE AND CELL THERAPY
Human Myoblast and Mesenchymal Stem Cell Interactions
Visualized by Videomicroscopy
Amanda B. Black,1 Heather Dahlenburg,1 Karen Pepper,1 Catherine Nacey,1
Suzanne Pontow,1 Maggie A. Kuhn,2 Peter C. Belafsky,2 and Jan A. Nolta1,*
1Stem Cell Program, Department Internal Medicine, and 2Department of Otolaryngology–Head
and Neck Surgery, University of California–Davis, Sacramento, California.
Muscle-derived progenitor cell (myoblast) therapy has promise for the treatment of denervated, weak-
ened, and fibrotic muscle. The best methods for injecting myoblasts to promote fusion and retention
have yet to be determined, however. Mesenchymal stem/stromal cells have also been reported to have
beneficial effects in restoring damaged tissue, through increasing vascularization and reducing in-
flammation. The interactions between human primary skeletal myoblasts and bone marrow-derived
mesenchymal stem/stromal cells were examined using time-lapse images put into video format. Of
interest, there is a high degree of cell-to-cell interaction with microparticles transferring between both
cell types, and formation of nanotubules to bridge cytoplasmic contents between the two types of cell.
This model provides an in vitro platform for examining mechanisms for cell-to-cell interaction preceding
myoblast fusion.
Figure 1. Single image captured from video showing interaction between human myoblasts labeled with a lentiviral vector carrying the eGFP gene and human
bone marrow-derived MSCs labeled with a lentiviral vector carrying the gene for Tomato Red. Microparticles shed from both cell types and extensive cell-to-
cell communication can be observed at (a) subconfluence and (b) confluence. Video link: TL(15,100%,TIFF,Norm,1X) (Converted)
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INTRODUCTION
AUTOLOGOUS MUSCLE-DERIVED PROGENITOR CELL
(myoblast) therapy has promise for the treatment of
denervated, weakened, and fibroticmuscle. Although
promising, there is room for improvement and the
best methods for injecting these progenitor cells have
yet to be determined. Key goals in the field are to
enhance understanding and to improve mechanisms
to enhance fusion of donor myoblast nuclei into mus-
cle fibers to promote the sustained retention needed
for myoblast therapy of skeletal muscle tissue.
Mesenchymal stem/stromal cells (MSCs) have
also been reported to have beneficial effects in
restoring damaged tissue, through increasing
vascularization, producing beneficial factors, and
reducing inflammation while temporarily modu-
lating the immune system (reviewed in refs.1–4).
The mechanisms that could contribute to im-
proved myoblast and MSC therapy, alone and
in combination, are under investigation by our
group and others.5 MSCs can promote an increase
in MMP-2/9 expression in myoblasts and stimulate
their mobilization, differentiation, and fusion.6
For donor myoblast fusion into the recipient fiber
to occur, the fusion partners must adhere their
membranes, open up fusion pores to allow cyto-
plasmicmaterial exchange, and thenmerge into one
cell.7 The study of muscle development in Droso-
phila has paved the way for understanding this
process, and knowledge is constantly updated.7,8
Proteins that could contribute to the process, pre-
viously implicated in the mammalian myoblast
fusion process, are nephrin,9 Kirrel,10 GRAF1,11 or
others currently under study.7 Increasing levels of
fusion of implanted myoblast nuclei into existing,
damaged muscle fibers is a significant goal.
We have studied the interactions between pri-
mary human skeletal myoblasts and human bone
marrow-derived MSCs using time-lapse images
(Figure 1) put into video format. The integration of
lentiviral vectors expressing enhanced green fluo-
rescent protein and tomato red in the two cell types,
respectively, allowed tracking of each cell in relation
to neighboring cells over time in the culture, with-
out photo-bleaching. The methods for videomicro-
scopy to examine MSC and myoblast interactions
over days in culture, as described in the current
report, represent an advance over current meth-
ods where fluorescent antibody-based dyes rapidly
blanch or leach out of the respective cell type.
In the current studies there was a high degree
of cell-to-cell interaction with production of visi-
ble microparticles by both cell types, as shown by
parcels of membrane-bound eGFP and tomato red
deposited behind the migrating cells, and formation
of nanotubules that could bridge communication and
potentially allow exchange of cytoplasmic material
between the two types of cell. When the microparti-
cles bind and release contents into a new target
cell, as observed in the Supplementary Video S1
(Supplementary Data are available online at www
.liebertpub.com/hgtb), there is not a yellow coloration
as when red and green are overlaid, but rather the
fluorescentmoleculesare rapidlyassimilated into the
target cell without a visible color change.
We have not seen obvious fusion of the two cell
types in vitro during the times studied (up to 96hr
of co-culture), although this data does not preclude
fusion in vivo. The model provides a platform for
examining factors that could promote better myo-
blast fusion. Fusion proteins of the factor under
study and the fluorescent molecules described here
(such as Kirrel-tomato red and nephrin-eGFP)
could be created to allow a direct observation of the
protein localization during interaction between the
two cell types.
We have previously described an ovine model
for tongue regeneration using autologous myo-
blasts.5 Our future goal is to co-administer autol-
ogous myoblasts with MSCs into the tongues of
human patients with severe dysphagia, to poten-
tially enhance the size and function of their muscle
tissue. The co-administration of MSCs could en-
hance survival, vascularization, and potentially
fusion of injected myoblasts. The type of durable
cell labeling followed by time-lapse imaging over a
period of days that we describe in this report is
useful to understand the cell-to-cell interactions
that occur between different types of cells that are
under consideration for co-administration to sites
of tissue damage in ‘‘next-generation’’ combination
cell therapy products.
METHODS
Lentivirus
To produce live, replication-incompetent lenti-
virus, Lenti-X 293 T-cells (Clontech) were trans-
fected with 25lg of the lentiviral transfer vectors,
25lg of pCMV-D8.9 (packaging plasmid express-
ing gag and pol), and 5 lg of pMDG-VSVG (vesic-
ular stomatitis virus glycoprotein-pseudotyping
envelope) using TransIT Reagent (Mirus Bio LLC),
following manufacturer’s instructions. One day
posttransfection, medium was changed to Ultra-
culture Serum Free Media (Lonza). The third day
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posttransfection (or two days after media change),
vector supernatants were collected and concen-
trated by ultrafiltration using Centricon Plus 70
filter units (Millipore) and then filtered through
0.45 lm Spin-X Centrifuge filter tubes (Costar).
The vectors were aliquoted and stored at -80C.
The viral titer was calculated by performing serial
dilutions of virus on target cells and assaying for
fluorescent reporter expression after 3 days.
Lentiviral transductions
Human myoblasts were transduced by the
lentiviral vector pCCLc-MNDU3-LUC-PGK-EGFP-
WPRE, and MSCs by lentiviral vector pCCLc-
MNDU3-tomato-WPRE. For each cell type used,
transduction efficiency as a function of MOI was
measured using a GFP-expressing vector in order
to adjust for differences in susceptibility to lenti-
virus between the cell types.
Transductions were performed by plating cells
at 6667 cells/cm2. The following day, lentivirus was
added to culture medium at an MOI of 40 in the
presence of 10lg/ml protamine sulfate (APP Phar-
maceuticals),usedto increasenonspecificviraluptake
by cells.12 Thenext day themediumwas replaced and
cells were cryopreserved four days posttransduction.
Transduction efficiency was determined by flow cy-
tometry for vectors containing fluorescent markers.
The MSCs labeled with the tomato vector were 87%
red, as assessed using flow cytometry.
Isolation and culture of bone marrow
mesenchymal stem cells
Whole bone marrow was purchased commer-
cially (Lonza) from normal donors. To isolate hu-
manMSCs, mononuclear cells were recovered from
25ml bone marrow aspirates with a Ficoll-Paque
density gradient (GEHealthcare) and resuspended
in complete culture medium (CCM), composed of
modified Eagle’s medium (MEMa) supplemented
with 10% Premium Select Fetal Bovine Serum
(Atlanta Biologicals), which was lot selected to
achieve maximum growth, with additives of 1%
penicillin/streptomycin and 1% L-glutamine. After
24hr, nonadherent cells were discarded, and ad-
herent cells were washed twice with PBS and then
incubated in fresh CCM.13,14 Cells were grown in
37C and 5% CO2. When MSCs reached approxi-
mately 60% confluency, cultures were lifted with
trypsin treatment and reseeded at 1000 cells/cm2.
The medium was changed every third day.
Culture of human myoblast human skeletal
muscle cells
Purchased human myoblasts (Gibco) were
thawed and plated on collagen-coated flasks (Corn-
ing) with myoblast media (MBM) and placed in a
37C 1% O2 incubator. MBM is composed of Ham’s
F-10 (Hyclone) with L-glutamine media supple-
mented with 20% Premium Select Fetal Bovine
Serum (Atlanta Biologicals), recombinant human
fibroblast growth factor (rhFGF; Gibco), and dexa-
methasone (Sigma-Aldrich).6 The medium was
changed every 2–3 days and cultures were trypsi-
nized when cells reached 60% confluency.6
Cocultures
MSCs cultured to 80% confluency andmyoblasts
cultured to 60% confluency were washed with PBS
and treated with TrypLE (Life Technologies) and
plated in a 1:1 ratio on collagen type I-coated dishes
(Corning).7 Cultures were maintained in MEMa/
Ham’s F-10 with L-glutamine combination media
supplemented with 20% FBS with rhFGF and dexa-
methasone. All cocultures were maintained at 37C
in 20% O2 and 5% CO2. Time-lapse images were
acquired using the Nikon Biostation IM (Nikon Inc.)
and of randomly selected locations within a single
culture dish over a 96hr period using phase-contrast
and filters for TRITC and FITC at both the 10· and
20· objectives. The images for each point were put
together to create time-lapse videos capturing the
cell-to-cell interactions occurring within the cocul-
ture over time.
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